Brendan P. Eckelman - Mar 8, 2024 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Signature
/s/ Kelly D. Deck, as attorney in fact for Brendan P. Eckelman
Stock symbol
INBX
Transactions as of
Mar 8, 2024
Transactions value $
-$1,403,546
Form type
4
Date filed
3/12/2024, 06:04 PM
Previous filing
Mar 2, 2023
Next filing
Mar 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Options Exercise -$76.9K -2.15K -5.38% $35.75 37.9K Mar 8, 2024 Common Stock 2.15K $33.63 Direct F1
transaction INBX Stock Option (right to buy) Options Exercise -$243K -6.88K -18.17% $35.30 31K Mar 11, 2024 Common Stock 6.88K $33.63 Direct F1, F2
transaction INBX Stock Option (right to buy) Options Exercise -$236K -6.68K -16.7% $35.33 33.3K Mar 11, 2024 Common Stock 6.68K $23.30 Direct F3
transaction INBX Stock Option (right to buy) Options Exercise -$701K -19.9K -64.24% $35.25 11.1K Mar 12, 2024 Common Stock 19.9K $33.63 Direct F1, F4
transaction INBX Stock Option (right to buy) Options Exercise -$146K -4.15K -12.46% $35.25 29.2K Mar 12, 2024 Common Stock 4.15K $23.30 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 15, 2022, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F2 The stock options were exercised in multiple transactions at prices ranging from $35.2927 to $35.3104, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F3 Twenty-five percent (25%) of the total shares subject to the stock option became exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.
F4 The stock options were exercised in multiple transactions at prices ranging from $35.25 to $35.325, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F5 The stock options were exercised in multiple transactions at prices ranging from $35.25 to $35.27, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.